tiprankstipranks
Veraxa Biotech (VRXA)
NASDAQ:VRXA
US Market
VRXA
Veraxa Biotech
RESEARCH TOOLSreports

Veraxa Biotech (VRXA) Stock News & Sentiment

14 Followers
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer
6d ago
VRXA
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
17d ago
VRXA
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase
20d ago
VRXA
VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision
21d ago
VRXA
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 
1M ago
VRXA
VERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
2M ago
VRXA
VERAXA Biotech (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
Premium
TipRanks Newswire
VERAXA Biotech (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
2M ago
VRXA
More VRXA News >

VRXA News on the Web

Top Veraxa Biotech Insider Makes Bold New Move in the Market
TipRanks News
Bullish
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
TipRanks News
Bullish
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase
TipRanks News
Bullish
VERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
TipRanks News
Bullish
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
TipRanks News
Bullish
VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition
TipRanks News
Bullish
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
rttnews
Bullish
VERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
VRXA
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRXA’s Media Buzz Sentiment?
1 articles about VRXA were published this week. In an average week, 2 articles are published.
    What is VRXA’s weekly average amount of articles?
    In an average week, 2 articles about VRXA are published.
      What is VRXA’s News Sentiment?
      100% of articles about VRXA were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week